|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
Statistics. CA Cancer J Clin. 60:277–300. 2010.
|
|
2
|
Ferlay J, Bray F, Pisani P and Parkin D:
GLOBOCAN 2002: Cancer incidence, mortality and prevalence
worldwide. IARC Press; Lyon: 2004
|
|
3
|
Blot WJ, McLaughlin JK, Winn DM, et al:
Source smoking and drinking in relation to oral and pharyngeal
cancer. Cancer Res. 48:3282–3287. 1988.PubMed/NCBI
|
|
4
|
Dahlstrom KR, Adler-Storthz K, Etzel CJ,
et al: Human papillomavirus type 16 infection and squamous cell
carcinoma of the head and neck in never-smokers: a matched pair
analysis. Clin Cancer Res. 9:2620–2626. 2003.PubMed/NCBI
|
|
5
|
Sturgis EM and Wei Q: Genetic
susceptibility – molecular epidemiology of head and neck cancer.
Curr Opin Oncol. 14:310–317. 2002.
|
|
6
|
Vineis P, Alavanja M, Buffler P, et al:
Tobacco and cancer: recent epidemiological evidence. J Natl Cancer
Inst. 96:99–106. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Franceschi S, Talamini R, Barra S, et al:
Smoking and drinking in relation to cancers of the oral cavity,
pharynx, larynx, and esophagus in northern Italy. Cancer Res.
50:6502–6507. 1990.PubMed/NCBI
|
|
8
|
Grant DM, Blum M, Beer M and Meyer UA:
Monomorphic and polymorphic human arylamine N-acetyltransferases: a
comparison of liver isozymes and expressed products of two cloned
genes. Mol Pharmacol. 39:184–191. 1991.PubMed/NCBI
|
|
9
|
Blum M, Demierre A, Grant DM, Heim M and
Meyer UA: Molecular mechanism of slow acetylation of drugs and
carcinogens in humans. Proc Natl Acad Sci USA. 88:5237–5241. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Smith CA, Smith G and Wolf CR: Genetic
polymorphisms in xenobiotic metabolism. Eur J Cancer.
30A:1921–1935. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hein DW: Acetylator genotype and
arylamine-induced carcinogenesis. Biochim Biophys Acta. 948:37–66.
1998.PubMed/NCBI
|
|
12
|
Butcher NJ, Boukouvala S, Sim E and
Minchin RF: Pharmacogenetics of the arylamine N-acetyltransferases.
Pharmacogenomics J. 2:30–42. 2002. View Article : Google Scholar
|
|
13
|
Cascorbi I, Brockmoller J, Mrozikiewicz
PM, Bauer S, Loddenkemper R and Roots I: Homozygous rapid arylamine
N-acetyltransferase (NAT2) genotype as a susceptibility factor for
lung cancer. Cancer Res. 56:3961–3966. 1996.PubMed/NCBI
|
|
14
|
Hein DW: N-acetyltransferase 2 genetic
polymorphism: effects of carcinogen and haplotype on urinary
bladder cancer risk. Oncogene. 25:1649–1658. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen J, Stampfer MJ, Hough HL, et al: A
prospective study of N-acetyltransferase genotype, red meat intake,
and risk of colorectal cancer. Cancer Res. 58:3307–3311.
1998.PubMed/NCBI
|
|
16
|
Katoh T, Boissy R, Nagata N, et al:
Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2
(NAT2) genes and susceptibility to gastric and colorectal
adenocarcinoma. Int J Cancer. 85:46–49. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lincz LF, Kerridge I, Scorgie FE, Bailey
M, Enno A and Spencer A: Xenobiotic gene polymorphisms and
susceptibility to multiple myeloma. Haematologica. 89:628–629.
2004.PubMed/NCBI
|
|
18
|
Zhang XF, Bian JC, Zhang XY, et al: Are
polymorphisms of N-acetyltransferase genes susceptible to primary
liver cancer in Luoyang, China? World J Gastroenterol.
11:1457–1462. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chatzimichalis M, Xenellis J,
Tzagaroulakis A, et al: GSTT1, GSTM1, GSTM3 and NAT2 polymorphisms
in laryngeal squamous cell carcinoma in a Greek population. J
Laryngol Otol. 124:318–323. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Demokan S, Suoglu Y, Gözeler M, Demir D
and Dalay N: N-acetyltransferase 1 and 2 gene sequence variants and
risk of head and neck cancer. Mol Biol Rep. 37:3217–3226. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Buch SC, Nazar-Stewart V, Weissfeld JL and
Romkes M: Case-control study of oral and oropharyngeal cancer in
whites and genetic variation in eight metabolic enzymes. Head Neck.
30:1139–1147. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Harth V, Schafer M, Abel J, et al: Head
and neck squamous-cell cancer and its association with polymorphic
enzymes of xenobiotic metabolism and repair. J Toxicol Environ
Health A. 71:887–897. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Boccia S, Cadoni G, Sayed-Tabatabaei FA,
et al: CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2
polymorphisms, smoking, consumption of alcohol and fruit and
vegetables and risk of head and neck cancer. J Cancer Res Clin
Oncol. 134:93–100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Majumder M, Sikdar N, Ghosh S and Roy B:
Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk
of oral leukoplakia and cancer among NAT2 slow acetylators. Int J
Cancer. 120:2148–2156. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rydzanicz M, Wierzbicka M, Gajecka M,
Szyfter W and Szyfter K: The impact of genetic factors on the
incidence of multiple primary tumors (MPT) of the head and neck.
Cancer Lett. 224:263–278. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gajecka M, Rydzanicz M, Jaskula-Sztul R,
Kujawski M, Szyfter W and Szyfter K: CYP1A1, CYP2D6, CYP2E1, NAT2,
GSTM1 and GSTT1 polymorphisms or their combinations are associated
with the increased risk of the laryngeal squamous cell carcinoma.
Mutat Res. 574:112–123. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hahn M, Hagedorn G, Kuhlisch E, Schackert
HK and Eckelt U: Genetic polymorphisms of drug-metabolizing enzymes
and susceptibility to oral cavity cancer. Oral Oncol. 38:486–490.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Varzim G, Monteiro E, Silva R, Pinheiro C
and Lopes C: Polymorphisms of arylamine N-acetyltransferase (NAT1
and NAT2) and larynx cancer susceptibility. ORL J Otorhinolaryngol
Relat Spec. 64:206–212. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen C, Ricks S, Doody DR, Fitzgibbons ED,
Porter PL and Schwartz SM: N-Acetyltransferase 2 polymorphisms,
cigarette smoking and alcohol consumption, and oral squamous cell
cancer risk. Carcinogenesis. 22:1993–1999. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jourenkova-Mironova N, Wikman H, Bouchardy
C, et al: Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and
NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal
cancers. Pharmacogenetics. 9:533–537. 1999.PubMed/NCBI
|
|
31
|
Henning S, Cascorbi I, Münchow B, Jahnke V
and Roots I: Association of arylamine N-acetyltransferases NAT1 and
NAT2 genotypes to laryngeal cancer risk. Pharmacogenetics.
9:103–111. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Morita S, Yano M, Tsujinaka T, et al:
Genetic polymorphisms of drug-metabolizing enzymes and
susceptibility to head-and-neck squamous-cell carcinoma. Int J
Cancer. 80:685–688. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Katoh T, Kaneko S, Boissy R, Watson M,
Ikemura K and Bell DA: A pilot study testing the association
between N-acetyltransferases 1 and 2 and risk of oral squamous cell
carcinoma in Japanese people. Carcinogenesis. 19:1803–1807. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
González MV, Alvarez V, Pello MF, Menéndez
MJ, Suárez C and Coto E: Genetic polymorphism of
N-acetyltransferase-2, glutathione S-transferase-M1, and
cytochromes P450IIE1 and P450IID6 in the susceptibility to head and
neck cancer. J Clin Pathol. 51:294–298. 1998.PubMed/NCBI
|
|
35
|
Hein DW, Doll MA, Fretland AJ, et al:
Molecular genetics and epidemiology of the NAT1 and NAT2
acteylation polymorphisms. Cancer Epidemiol Biomarkers Prev.
9:29–42. 2000.PubMed/NCBI
|
|
36
|
Vatsis KP, Martell Kj and Weber WW:
Diverse point mutations in the human gene for polymorphic
N-acetyltranferase. Proc Natl Acad Sci USA. 88:6333–6337. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shen X, Zhang J, Yan Y, Yang Y, Fu G and
Pu Y: Analysis and estimates of the attributable risk for
environmental and genetic risk factors in gastric cancer in a
Chinese population. J Toxicol Environ Health A. 72:759–766. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ladero JM, Agúndez JA, Olivera M, et al:
N-acetyltransferase 2 single-nucleotide polymorphisms and risk of
gastric carcinoma. Eur J Clin Pharmacol. 58:115–118. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang YW, Eom SY, Kim YD, et al: Effects
of dietary factors and the NAT2 acetylator status on gastric cancer
in Koreans. Int J Cancer. 125:139–145. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Boccia S, Sayed-Tabatabaei FA, Persiani R,
et al: Polymorphisms in metabolic genes, their combination and
interaction with tobacco smoke and alcohol consumption and risk of
gastric cancer: a case-control study in an Italian population. BMC
Cancer. 7:2062007. View Article : Google Scholar
|
|
41
|
Chiou HL, Wu MF, Chien WP, et al: NAT2
fast acetylator genotype is associated with an increased risk of
lung cancer among never-smoking women in Taiwan. Cancer Lett.
223:93–101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zupa A, Sgambato A, Bianchino G, et al:
GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer
risk: a case-control study. Anticancer Res. 29:1709–1714.
2009.PubMed/NCBI
|
|
43
|
Borlak J and Reamon-Buettner SM:
N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung
cancer patients. BMC Med Genet. 7:582006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hamasaki T, Inatomi H, Katoh T, et al:
N-acetyltransferase-2 gene polymorphism as a possible biomarker for
prostate cancer in Japanese men. Int J Urol. 10:167–173. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hein DW, Leff MA, Ishibe N, et al:
Association of prostate cancer with rapid N-acetyltransferase 1
(NAT1*10) in combination with slow N-acetyltransferase 2 acetylator
genotypes in a pilot case-control study. Environ Mol Mutagen.
40:161–167. 2002.
|
|
46
|
Iguchi T, Sugita S, Wang CY, et al: MnSOD
genotype and prostate cancer risk as a function of NAT genotype and
smoking status. In Vivo. 23:7–12. 2009.PubMed/NCBI
|
|
47
|
Gara S, Abdennebi M, Chatti S, Touati S,
Ladgham A and Guemira F: Association of NAT2 gene substitution
mutation T341C with increased risk for head and neck cancer in
Tunisia. Acta Oncol. 46:834–837. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Unal M, Tamer L, Akbaş Y, et al: Genetic
polymorphism of N-acetyltransferase 2 in the susceptibility to
laryngeal squamous cell carcinoma. Head Neck. 27:1056–1060. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lei D, Pan X, Guo C, et al: Relationship
between polymorphism of N-acetyltransferase 2 and genetic
susceptibility to laryngeal carcinoma. Zhonghua Zhong Liu Za Zhi.
24:154–156. 2002.PubMed/NCBI
|
